Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident

NCT04694001 is registered in ClinicalTrials.gov with Wandercraft as lead sponsor.

NCT NCT04694001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04694001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident
Lead sponsor
Wandercraft
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2021
Completion date
March 28, 2022
Enrollment
40 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stroke, stroke, stroke, acute, stroke, subacute